Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy

Authors

  • Jing Liu University of Toledo,department of medicine
  • Yan Ge
  • Lance Dworkin
  • Rujun Gong

DOI:

https://doi.org/10.46570/utjms-2025-1354

Keywords:

thrombospondin type 1 domain containing 7A, membranous nephropathy, melanocortin 5 receptor, melanocortin therapy

Downloads

Published

2025-06-30

How to Cite

Liu, J., Ge, Y., Dworkin, L., & Gong, R. (2025). Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy. Translation: The University of Toledo Journal of Medical Sciences, 13(S3). https://doi.org/10.46570/utjms-2025-1354

Issue

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium